NEW YORK, March 24 (GenomeWeb News) - Shares in Affymetrix were up 6.4 percent since since Tuesday's closing price after an analyst for Cairns & Company yesterday raised the stock to "Above Average" from a "Buy." 

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.